Z
Zentalis Pharmaceuticals, Inc.
ZNTL · NASDAQ · Healthcare · 253M
Closing price
$2.64
+5.18% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
0.9×
Enterprise value / EBITDAEV/EBITDA
-1.3×
Free cash flow yieldFCF yield
-66.0%
Return on equityROE
-63.4%
Operating margin
—
Net debt / EBITDAbalance-sheet strength
-0.0×
Interest coverage
—
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.